TIAA Trust National Association Has $4.11 Million Holdings in AMETEK, Inc. $AME

TIAA Trust National Association lessened its position in shares of AMETEK, Inc. (NYSE:AMEFree Report) by 14.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,992 shares of the technology company’s stock after selling 3,438 shares during the quarter. TIAA Trust National Association’s holdings in AMETEK were worth $4,105,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in shares of AMETEK during the 2nd quarter worth approximately $25,000. CoreCap Advisors LLC grew its holdings in shares of AMETEK by 84.3% during the 4th quarter. CoreCap Advisors LLC now owns 129 shares of the technology company’s stock worth $26,000 after purchasing an additional 59 shares in the last quarter. BOKF NA grew its holdings in shares of AMETEK by 137.7% during the 4th quarter. BOKF NA now owns 145 shares of the technology company’s stock worth $30,000 after purchasing an additional 84 shares in the last quarter. Flagship Harbor Advisors LLC acquired a new stake in shares of AMETEK during the 4th quarter worth approximately $32,000. Finally, ORG Partners LLC grew its holdings in shares of AMETEK by 42.6% during the 4th quarter. ORG Partners LLC now owns 201 shares of the technology company’s stock worth $41,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

AMETEK Price Performance

Shares of AME stock opened at $221.91 on Thursday. The stock’s fifty day simple moving average is $228.52 and its 200 day simple moving average is $220.12. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.14 and a quick ratio of 0.72. The firm has a market cap of $50.86 billion, a price-to-earnings ratio of 33.52, a P/E/G ratio of 3.22 and a beta of 1.00. AMETEK, Inc. has a one year low of $174.43 and a one year high of $243.18.

AMETEK (NYSE:AMEGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The technology company reported $1.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.07. AMETEK had a return on equity of 16.63% and a net margin of 20.11%.The firm had revenue of $1.93 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the previous year, the company posted $1.75 EPS. The business’s revenue for the quarter was up 11.3% compared to the same quarter last year. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. On average, analysts expect that AMETEK, Inc. will post 8.13 earnings per share for the current fiscal year.

AMETEK Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be given a $0.34 dividend. The ex-dividend date is Monday, June 15th. This represents a $1.36 annualized dividend and a yield of 0.6%. AMETEK’s payout ratio is presently 20.54%.

Insider Transactions at AMETEK

In other AMETEK news, Director Thomas A. Amato sold 530 shares of AMETEK stock in a transaction on Tuesday, March 24th. The stock was sold at an average price of $216.78, for a total value of $114,893.40. Following the completion of the transaction, the director owned 4,480 shares in the company, valued at approximately $971,174.40. The trade was a 10.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.54% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on AME. DA Davidson reaffirmed a “buy” rating and issued a $265.00 price target on shares of AMETEK in a research note on Monday, May 4th. Robert W. Baird set a $244.00 price target on AMETEK in a research note on Friday, May 1st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, May 20th. Wall Street Zen lowered AMETEK from a “buy” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $275.00 price target (up from $265.00) on shares of AMETEK in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $252.33.

Read Our Latest Stock Report on AMETEK

AMETEK Company Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Articles

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.